Psychopharmacology : a concise overview / Arash Ansari, M.D., David N. Osser, M.D.

Format:

Book

Author/Creator:

Ansari, Arash, author.

Osser, David N. (David Neal), author.

Contributor:

Oxford University Press.

Louis B. Flexner Medical Book Fund.

Language:

English

Subjects (All):

Psychopharmacology.

Psychotropic drugs.

Physical Description:

1 online resource (xvii, 348 pages)

Edition:

Third edition.

Place of Publication:

New York, NY : Oxford University Press, [2020]

System Details:

text file

Summary:

Psychopharmacology: A Concise Overview, 3rd Edition is an evidence-based overview of the major classes of psychiatric medications and their use in clinical practice. Clinical considerations as to when, why, and how to use each individual medication are discussed in depth, as are relevant clinical controversies and treatment caveats. Each chapter also features an updated table of individual medications and their generic and brand names, dosing information, pertinent clinical comments, black box warnings, and Food and Drug Administration indications. This overview will equip readers with an essential framework of the concepts of psychopharmacology in an accessible length and style ideal for use as either a primer or refresher text. Medical students, residents, practicing physicians, nurse practitioners and other prescribers, as well as non-prescribing mental health clinicians who need to have a functional familiarity with available pharmacotherapies, will benefit from reading this concise book.

Contents:

1 Antidepressants p. 15

Tricyclic Antidepressants p. 17

Monoamine Oxidase Inhibitors p. 19

Selective Serotonin Reuptake Inhibitors p. 21

Serotonin-Norepinephrine Reuptake Inhibitors p. 28

Antidepressants With Other Mechanisms of Action p. 30

Emerging Pharmacotherapies p. 33

Complementary, Alternative, and Other Pharmacotherapies p. 35

Further Notes on the Clinical Use of Antidepressants for Unipolar Depression p. 37

Do Antidepressants Work? p. 37

Starting, Continuing, and Terminating Antidepressant Therapy p. 38

First-Line Treatments p. 40

Outcome Studies p. 41

Monotherapy Versus Combination Antidepressants p. 43

Treatment-Resistant Depression p. 44

Clinical Use of Antidepressants in Other Psychiatric Disorders p. 45

Post-Myocardial Infarction Depression p. 46

Post-Stroke Depression p. 46

Depression in Parkinson's Disease p. 46

Eating Disorders p. 47

Premenstrual Dysphoric Disorder p. 48

Perimenopausal Depression p. 48

Clinical Use of Antidepressants in Nonpsychiatric Disorders p. 48

Irritable Bowel Syndrome p. 49

Functional Dyspepsia and Gastroparesis p. 49

Use in Women of Childbearing Potential, Pregnancy, and Breastfeeding p. 49

Pregnancy p. 49

Breastfeeding p. 52

Table of Antidepressants p. 52

2 Anti-Anxiety Medicines and Hypnotics p. 85

Benzodiazepines p. 86

Barbiturates p. 90

Medicines Without Abuse Potential Used for the Treatment of Anxiety p. 90

Hypnotics p. 95

Complementary, Alternative, and Other Pharmacotherapies p. 98

Further Notes on the Clinical Use of Anxiolytics and Hypnotics p. 99

Anxiety Disorders p. 99

Insomnia p. 101

Treatment-Resistant Anxiety and Insomnia p. 102

Use in Women of Childbearing Potential, Pregnancy, and Breastfeeding p. 103

Pregnancy p. 103

Breastfeeding p. 104

Table of Non-Antidepressant Medicines for Anxiety and Insomnia p. 104

3 Antipsychotics p. 121

First-Generation Antipsychotics p. 121

Second-Generation Antipsychotics p. 126

Newer Second-Generation Antipsychotics p. 136

Newest Second-Generation Antipsychotics p. 138

Emerging Antipsychotic p. 139

Complementary, Alternative, and Other Pharmacotherapies p. 140

Further Notes on the Clinical Use of Antipsychotics in Psychotic Disorders p. 141

Choice of Antipsychotic p. 141

Time to Response p. 144

Treatment Continuation p. 145

Antipsychotics for Acute Behavioral Control p. 146

Long-Acting Injectable Antipsychotics p. 148

Treatment-Resistant Schizophrenia p. 150

Clinical Use of Antipsychotics in Other Psychiatric Disorders p. 151

Anxiety p. 151

Unipolar Depression p. 152

Bipolar Disorder p. 152

Eating Disorders p. 154

Personality Disorders p. 154

Clinical Use of Antipsychotics in Nonpsychiatric Disorders p. 155

Use in Women of Childbearing Potential, Pregnancy, and Breastfeeding p. 155

Pregnancy p. 155

Breastfeeding p. 157

Table of Antipsychotics p. 157

4 Mood Stabilizers p. 185

Lithium and Anticonvulsants Used as Mood Stabilizers p. 185

Antipsychotics Used as Mood Stabilizers p. 195

Mania p. 195

Bipolar Depression p. 195

Bipolar Maintenance p. 196

Other Anticonvulsants p. 197

Emerging Pharmacotherapies p. 198

Complementary, Alternative, and Other Pharmacotherapies p. 199

Further Notes on the Clinical Use of Mood Stabilizers for Bipolar Disorder p. 200

Summary of Initial Therapies for Each Phase of Bipolar Disorder p. 201

On the Clinical Use of Antidepressants in Bipolar Disorder p. 203

Treatment-Resistant Bipolar Disorder p. 206

Clinical Use of Mood Stabilizers in Other Psychiatric Disorders p. 207

Unipolar Depression p. 207

Aggression and Impulsivity p. 208

Dementia p. 208

Clinical Use of Mood Stabilizers in Nonpsychiatric Disorders p. 209

Pain p. 209

Use in Women of Childbearing Potential, Pregnancy, and Breastfeeding p. 209

Pregnancy p. 209

Breastfeeding p. 211

Table of Mood Stabilizing Medicines p. 212

5 Stimulants and Other ADHD Medicines p. 231

Stimulants p. 232

Nonstimulant Medicines for ADHD p. 238

Complementary, Alternative, and Other Pharmacotherapies p. 241

Further Notes on the Clinical Use of Medicines for Adult ADHD p. 241

Starting Pharmacotherapy in Adults p. 242

Drug Holidays p. 243

Long-Term Use p. 244

ADHD and Sleep p. 244

Treatment of ADHD in College Students p. 245

Treatment-Resistant ADHD p. 248

Clinical Use of Stimulants in Other Psychiatric Disorders p. 249

Unipolar Depression p. 249

Bipolar Depression p. 250

Binge-Eating Disorder p. 250

Clinical Use of Stimulants in Nonpsychiatric Disorders p. 251

Fatigue p. 251

Use in Women of Childbearing Potential, Pregnancy, and Breastfeeding p. 251

Pregnancy p. 251

Breastfeeding p. 252

Table of ADHD Medicines p. 252

6 Treatments for Substance Use Disorders p. 267

Medicines for Opioid Use Disorder p. 268

Medicines for Alcohol Use Disorder p. 274

Other Potentially Effective Medicines for Alcohol Use Disorder p. 278

Medicines for Tobacco Use Disorder p. 282

Medicines for Other Substance Use Disorders p. 286

Cocaine Use Disorder p. 287

Cannabis Use Disorder p. 287

Amphetamine Use Disorder p. 288

Complementary, Alternative, and Other Pharmacotherapies p. 288

Opioid Use Disorders p. 288

Alcohol Use Disorder p. 289

Tobacco Use Disorder p. 289

Further Notes on the Clinical Use of Medicines for Substance Use Disorders p. 289

Initiating and Continuing Treatment p. 290

Treatment-Resistant Substance Use Disorders p. 294

Use in Women of Childbearing Potential, Pregnancy, and Breastfeeding p. 297

Pregnancy p. 297

Breastfeeding p. 300

Table of Medicines for Substance Use Disorders p. 301.

Notes:

Includes bibliographical references and index.

Electronic reproduction. Oxford Available via World Wide Web.

Description based on online resource; title from digital title page (viewed on November 03, 2020).

Local Notes:

Acquired for the Penn Libraries with assistance from the Louis B. Flexner Medical Book Fund.

Other Format:

Print version: Ansari, Arash. Psychopharmacology

ISBN:

9780197537077

0197537073

9780197537060

0197537065

Publisher Number:

99985519459

Access Restriction:

Restricted for use by site license.